We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.78B
AUM Growth
-$305M
(-4.3%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-15.36%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
1,363
New
346
Increased
312
Reduced
313
Closed
357
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$251M |
| 2 |
AGN
Allergan plc
AGN
|
+$209M |
| 3 |
Cigna
CI
|
+$106M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$77.7M |
| 5 |
Labcorp
LH
|
+$52.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$368M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$354M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$331M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$224M |
| 5 |
Brookdale Senior Living
BKD
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.37% |
| 2 | Consumer Discretionary | 6.42% |
| 3 | Industrials | 5.53% |
| 4 | Financials | 5.32% |
| 5 | Technology | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKS
701
PUT
DELISTED
AK Steel Holding Corp
AKS
| $405K | 0.01% |
+10,000
| New | +$43.6K |
|
|
LNKD
702
DELISTED
LinkedIn Corporation
LNKD
| $400K | 0.01% |
+1,600
| New | +$397K |
|
703
M&T Bank
MTB
$36.2B
| $399K | 0.01% |
+3,138
| New | +$380K |
|
|
TSRO
704
DELISTED
TESARO, Inc.
TSRO
| $398K | 0.01% |
+6,941
| New | +$327K |
|
705
Jabil
JBL
$33.4B
| $397K | 0.01% |
17,000
+100
| +0.6% | +$2.18K |
|
706
Booz Allen Hamilton
BAH
$8.56B
| $396K | 0.01% |
13,668
-6,590
| -33% | -$192K |
|
707
NetApp
NTAP
$35.9B
| $396K | 0.01% |
11,170
-15,201
| -58% | -$581K |
|
708
SLR Investment Corp
SLRC
$709M
| $395K | 0.01% |
19,493
-49,307
| -72% | -$957K |
|
709
American Water Works
AWK
$26.1B
| $394K | 0.01% |
7,262
+1,842
| +34% | +$100K |
|
|
CELG
710
DELISTED
Celgene Corp
CELG
| $392K | 0.01% |
3,400
+1,000
| +42% | +$119K |
|
711
FirstEnergy
FE
$28B
| $390K | 0.01% |
11,113
-2,072
| -16% | -$77.5K |
|
712
FTI Consulting
FCN
$4.37B
| $389K | 0.01% |
+10,384
| New | +$392K |
|
713
Regis Corp
RGS
$68.7M
| $389K | 0.01% |
1,188
+638
| +116% | +$208K |
|
|
AMTD
714
DELISTED
TD Ameritrade Holding Corp
AMTD
| $389K | 0.01% |
10,442
-4,758
| -31% | -$169K |
|
|
SBNY
715
DELISTED
Signature Bank
SBNY
| $386K | 0.01% |
2,980
-12,147
| -80% | -$1.51M |
|
716
HF Sinclair
DINO
$15.8B
| $385K | 0.01% |
9,571
-3,389
| -26% | -$130K |
|
717
Deckers Outdoor
DECK
$13.6B
| $381K | 0.01% |
31,338
-29,406
| -48% | -$378K |
|
|
PCL
718
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $380K | 0.01% |
8,748
-500
| -5% | -$21.8K |
|
719
United Airlines
UAL
$41.7B
| $377K | 0.01% |
5,600
-4,140
| -43% | -$280K |
|
720
ConocoPhillips
COP
$145B
| $374K | 0.01% |
+6,000
| New | +$388K |
|
721
Telefônica Brasil
VIV
$20.3B
| $374K | 0.01% |
+24,491
| New | +$433K |
|
722
Charles River Laboratories
CRL
$11.1B
| $373K | 0.01% |
+4,705
| New | +$347K |
|
|
CVSA
723
Covista Inc
CVSA
$4.34B
| $370K | 0.01% |
+11,095
| New | +$431K |
|
724
Tapestry
TPR
$31.4B
| $370K | 0.01% |
8,937
+2,137
| +31% | +$85K |
|
725
Nektar Therapeutics
NKTR
$2.38B
| $366K | 0.01% |
+2,216
| New | +$455K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Visium Asset Management held 1,363 positions worth $6.78B, down 4.3% from $7.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management withdrew a net $1.04B in Q1 2015, closing 357 positions and reducing 313 holdings. Its most notable exit was Allergan Inc, an estimated $368M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Visium Asset Management opened a new position in Akorn Inc worth $25.3M.
- Visium Asset Management's largest Q1 2015 buy was Akorn Inc: 533,000 shares worth $25.3M.
- Visium Asset Management added most to Perrigo in Q1 2015, an estimated $251M increase.
- Visium Asset Management's biggest Q1 2015 reduction was Endo International plc, cutting an estimated $331M.
- Visium Asset Management fully exited Allergan Inc in Q1 2015, selling an estimated $368M.
- Visium Asset Management's ten largest holdings make up 29% of its $6.78B portfolio in Q1 2015.
- Visium Asset Management opened 346 new positions and closed 357 in Q1 2015.
- Visium Asset Management's portfolio value fell 4.3% quarter-over-quarter to $6.78B.
Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.